The role of interleukin-33 in patients with mild cognitive impairment and Alzheimer's disease.

Alzheimer's Research & Therapy
Chih-Sung LiangFu-Chi Yang

Abstract

The neuroprotective role of interleukin (IL)-33 is supported by numerous preclinical studies, but it remains uninvestigated in clinical studies of Alzheimer's disease (AD). We aimed to examine the association between human blood levels of IL-33 and cognitive preservation in amnestic mild cognitive impairment (aMCI) and AD. A total of 100 participants (26 controls, 35 aMCI patients, and 39 AD patients) completed two Mini-Mental State Examinations (MMSEs) over a 1-year interval. In all 100 participants at the second MMSE, we examined the plasma levels of IL-33, IL-β, IL-1 receptor agonist (IL-1RA), beta amyloid (Aβ), and tau and apolipoprotein E (ApoE) genotyping; we also performed Hopkins Verbal Learning Test, Trail Making Test, forward and backward digit span, and Clinical Dementia Rating. IL-33 expression showed a positive trend among controls (1/26 = 3.8%), aMCI (9/35 = 25.7%), and AD (17/39 = 43.6%) (trend analysis: P < 0.001). Patients expressing IL-33 preserved their cognitive function compared with IL-33 non-expressing patients (1-year ΔMMSE, 0.16 ± 1.6 vs - 1.5 ± 2.6; P = 0.006). The cognitive preservation was not associated with the lower levels of Aβ, tau, and ApoE ε4, while higher levels of ApoE ε4 and phosphorylated ...Continue Reading

References

Aug 31, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Solomon S ShaftelM Kerry O'Banion
Jul 8, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shafaqat AliMichael Uwe Martin
Mar 15, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Simantini GhoshM Kerry O'Banion
Oct 15, 2014·Proceedings of the National Academy of Sciences of the United States of America·Emma LefrançaisJean-Philippe Girard
Apr 17, 2015·Alzheimer's Research & Therapy·Peter ThériaultSerge Rivest
May 21, 2015·Nature Reviews. Neuroscience·Frank L HeppnerBurkhard Becher
Jun 27, 2015·Brain, Behavior, and Immunity·Paula KorhonenTarja Malm
Apr 20, 2016·Proceedings of the National Academy of Sciences of the United States of America·Amy K Y FuNancy Y Ip
Jun 7, 2016·Alzheimer's Research & Therapy·Malin Degerman GunnarssonLena Kilander
Oct 27, 2016·Nature Reviews. Immunology·Foo Yew LiewHeth Roderick Turnquist
Mar 6, 2017·Alzheimer's Research & Therapy·Róisín M McManus, Michael T Heneka
May 10, 2017·The Journal of Allergy and Clinical Immunology·Hideaki MoritaKenji Matsumoto
Dec 3, 2017·Scientific Reports·Francesca La RosaMario Clerici
Nov 21, 2018·Alzheimer's Research & Therapy·Roger N RosenbergDoris Lambracht-Washington
Feb 2, 2019·Alzheimer's Research & Therapy·Omar A HalawaUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Mar 25, 2019·Alzheimer's Research & Therapy·Carla M StartinAndré Strydom
Jan 2, 2020·Alzheimer's Research & Therapy·Samir Abu-RumeilehPiero Parchi

❮ Previous
Next ❯

Citations

Aug 7, 2021·Journal of Multidisciplinary Healthcare·Meirong Xu, Ganlin Wu

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Software Mentioned

GraphPad Prism
SPSS
Plex Manager
Bio

Related Concepts

Related Feeds

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.